Cheplapharm Arzneimittel GmbH | Finanzwire

Basculer en Français

10482	Companies
220830	Keywords
150169	Articles
116819	Press releases

Headlines Articles Press releases Cheplapharm Arzneimittel GmbH

Home
Companies
Cheplapharm Arzneimittel GmbH

BRIEF

published on 06/01/2026 at 09:49, 15 hours 11 minutes ago

Martin Krämer Appointed as New CFO at CHEPLAPHARM

Pharmaceutical Industry Financial Management CFO Appointment CHEPLAPHARM Martin Krämer
PRESS RELEASE

published on 06/01/2026 at 09:44, 15 hours 16 minutes ago

MARTIN KRÄMER BECOMES THE NEW CHIEF FINANCIAL OFFICER AT CHEPLAPHARM
Martin Krämer is appointed as the new Chief Financial Officer at CHEPLAPHARM, bringing extensive international financial management experience from Röhm. He succeeds Dr Parssanedjad, enhancing the company's financial organization

Financial Management CFO CHEPLAPHARM International Experience Martin Krämer
BRIEF

published on 05/18/2026 at 08:50, 14 days 16 hours ago

CHEPLAPHARM Aligns Management Board for Strategic Growth

Growth Strategy Leadership Changes Management Board Pharmaceutical Partnerships CHEPLAPHARM
PRESS RELEASE

published on 05/18/2026 at 08:45, 14 days 16 hours ago

CHEPLAPHARM ALIGNS ITS MANAGEMENT BOARD FOR NEXT PHASE OF GROWTH
Cheplapharm reorganizes its Management Board to focus on strategic growth through transactions and partnerships, appoints Dr Keyarasch Parssanedjad as Chief Business & Strategy Officer, and Martin Krämer as CFO

Transactions Growth Management Board Partnerships CHEPLAPHARM
BRIEF

published on 04/29/2026 at 13:05, 1 month 2 days ago

Cheplapharm Sees Revenue Growth in 2025

Pharmaceutical Industry Revenue Growth EBITDA Margin Financial Stability CHEPLAPHARM
PRESS RELEASE

published on 04/29/2026 at 13:00, 1 month 2 days ago

CHEPLAPHARM reports Revenue Growth in the 2025 Financial Year
CHEPLAPHARM reports 8.1% revenue growth reaching €1.66 billion in FY2025. EBITDA at €642.8 million with a 38.8% margin. Employee count up 2% to 799

Financial Results EBITDA Revenue Growth CHEPLAPHARM Employee Count
BRIEF

published on 02/02/2026 at 15:41, 3 months 27 days ago

CHEPLAPHARM's Successful €950m Bond Issuance

Refinancing Bond Issuance Financial Strategy Investor Demand CHEPLAPHARM
PRESS RELEASE

published on 02/02/2026 at 15:36, 3 months 27 days ago

Successful Refinancing: CHEPLAPHARM'S new 6.750% Bond multiple times oversubscribed
CHEPLAPHARM successfully refinances with new 6.750% bond oversubscribed multiple times, enhancing financial flexibility and maturity profile

Refinancing Oversubscribed Financial Flexibility CHEPLAPHARM 6.750% Bond
BRIEF

published on 08/27/2025 at 13:34, 9 months 5 days ago

CHEPLAPHARM Reports Stable Growth in the First Half of 2025

Pharmaceutical Industry Revenue Growth Transformation Program CHEPLAPHARM Employee Expansion
PRESS RELEASE

published on 08/27/2025 at 13:29, 9 months 5 days ago

CHEPLAPHARM with stable business in the first half of 2025
Cheplapharm AG reports stable business performance in the first half of 2025, with revenue up by 12% and EBITDA up by 24% compared to the second half of 2024

Financial Results Transformation Program Stability Acquisition Opportunities Cheplapharm AG

Accesswire

Published on 06/02/2026 at 00:00, 1 hour ago

Boron One Announces Financing
Published on 06/01/2026 at 23:57, 1 hour 3 minutes ago

Metallic Minerals Announces Bought Deal LIFE Private Placement for Gross Proceeds of C$8.0 Million
Published on 06/01/2026 at 23:05, 1 hour 55 minutes ago

Faraday Copper Strengthens Team to Support Project Advancement in Arizona
Published on 06/01/2026 at 23:00, 2 hours ago

CCL Industries Closing of Sleever International Acquisition
Published on 06/01/2026 at 22:30, 2 hours 30 minutes ago

Revolve to Present at the Small Cap Growth Virtual Investor Conference on June 4, 2026

View all ACCESSWIRE

EQS Group

Published on 06/01/2026 at 23:00, 2 hours ago

DriveNets Secures $410M Series D to Meet Surging Demand for Ethernet Fabric in Large-Scale AI Deployments
Published on 06/01/2026 at 22:05, 2 hours 55 minutes ago

EUROPEAN COMMISSION APPROVES AMGEN'S IMDYLLTRA® FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Published on 06/01/2026 at 22:05, 2 hours 55 minutes ago

Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis
Published on 06/01/2026 at 21:20, 3 hours 40 minutes ago

Eurobattery Minerals: Loft Capital exercises conversion rights – Conversion Threshold Date reached and a total of 23,798,419 new shares to be registered
Published on 06/01/2026 at 19:00, 6 hours ago

Armen Pogossian Represents Armenia at Forbes Under 30 Summit China, Empowering the Next Generation of Global Entrepreneurs

Les Echos

Published on 06/01/2026 at 18:47, 6 hours 13 minutes ago

Disclosure of transactions in own shares from May 25 to May 29, 2026
Published on 06/01/2026 at 18:00, 7 hours ago

Covivio - Information on total number of voting rights and share capital
Published on 06/01/2026 at 17:54, 7 hours 6 minutes ago

Reporting on share buyback transactions carried out on May 28, 2026
Published on 06/01/2026 at 17:54, 7 hours 6 minutes ago

TF1 - Monthly disclosure of the total number of shares and voting rights - May 2026
Published on 06/01/2026 at 17:45, 7 hours 15 minutes ago

ENGIE secures €1 billion export financing backed by Euler Hermes

View all LES ECHOS COMFI WIRE